What Happened?
South San Francisco, CA-based Ideaya-Biosciences Appointed Yujiro Hata as Chief Executive Officer
About the Company
Ideaya Biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. Founded in 2015, IDEAYA`s investors include 5AM Ventures (5AM), Canaan Partners (Canaan), Celgene, WuXi Healthcare Ventures (WuXi), Novartis Institute of Biomedical Research, and Alexandria Real Estate. The Company has assembled a world-class drug discovery team and Scientific Advisory Board (SAB) that is represented by a Nobel Laureate and three Members of the National Academy of Sciences. IDEAYA is located in South San Francisco and La Jolla, California.
About the Person
Yujiro Hata is Chief Executive Officer at Ideaya Biosciences. Previously, Yujiro held various senior HR leadership roles in the industry.
Info Source
News
Short Profile